[Surgery of hepatobiliary tumors]

Area of Science:

• Hepatobiliary surgery
• Surgical oncology
• Tumor staging

Context:

• Hepatobiliary tumors, including colorectal liver metastases, hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma, are treated with R0 resection.
• Lymph node metastasis is a significant prognostic factor in these cancers.
• The role of systematic lymph node dissection in improving outcomes for hepatobiliary tumors is not well-established due to limited prospective trials.

Purpose:

• To evaluate the prognostic value of lymph node dissection in hepatobiliary tumors.
• To assess the feasibility and impact of local lymphadenectomy on patient staging.
• To highlight the need for further randomized trials to clarify the role of lymphadenectomy.

Summary:

• R0 resection offers the only potential cure for primary and secondary hepatobiliary tumors.
• While lymph node metastasis is a known prognostic factor, the benefit of systematic lymph node dissection remains unclear.
• Local lymphadenectomy is technically feasible with low risk and can aid in patient staging, but its definitive role requires further investigation.

Impact:

• Provides insights into the current understanding of lymph node dissection in hepatobiliary cancer surgery.
• Emphasizes the need for high-quality evidence from randomized trials to guide clinical practice.
• Contributes to the ongoing discussion on optimizing staging and treatment strategies for hepatobiliary malignancies.